INSIGHTS ON PHARMACEUTICAL LOGISTICS
-
Top Safety Considerations In Biopharmaceutical Manufacturing
Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.
-
Biopharma Supply, Reimagined: Regional, Resilient Manufacturing
Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.
-
Building A Purification Toolkit For An Expanding Variety Of mAb Therapeutics
Explore techniques for optimizing purification toolkits for various monoclonal antibody formats. This session covers resin and buffer selection for efficient downstream process development.
-
The Future Of RNA Manufacturing Starts With Raw Material Innovation
Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.
-
Building A Resilient Supply Chain For Your Next-Generation Peptide Therapeutic1/23/2025
As peptide therapeutics continue to establish themselves as a leading technology for treating chronic indications, drug sponsors must identify reliable peptide building block suppliers to secure high-quality starting materials.
-
Risk Mitigation For Late-Stage Clinical Assets6/11/2025
Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.
-
Supply Resiliency For Bioprocessing Amid Global Volatility10/2/2025
Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.
-
Moving Batch Release Into The Fast Lane1/21/2026
Complex supply chains and fragmented systems slow batch release, delaying patient access and revenue goals. Learn how automation and centralized data improve compliance and accelerate delivery.
-
Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics1/22/2025
Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.
PHARMACEUTICAL LOGISTICS SOLUTIONS
-
Partner with SK pharmteco for reliable, ICH-compliant stability testing and storage solutions, supported by expert scientists and fully qualified chambers to ensure the safety and efficacy of your CGMP products.
-
V11 Label Inspection System
Adaptable, integrable, and cost-effective. This flexible label inspection solution reliably inspects oriented products from the sides or top for label data and quality defects. It can be easily integrated into existing production lines utilizing smart cameras, lighting, and software.
100% Automated Label Inspection
Affordable vision system ideally suited to replace manual spot checks with 100% automated label inspection control for high-speed production lines.
Compliance Support
The V11 provides documented label inspection in line with industry guidelines such as IFS and BRCGS to support consumer safety.
Prevent Recalls and Reduce Waste
The V11 verifies labels to detect and reliably sort non-conforming products. False or missing declarations often lead to costly recalls.
-
GORE STA-PURE Flexible Freeze Containers are durable single-use containers for cold chain handling of bulk drug substance. Intended for storing and transporting bulk drug substances after freezing at -86°C (-123°F), GORE STA-PURE Flexible Freeze Containers are resistant to cracks, leaks or breaks during cold-chain handling.
-
Receive comprehensive stability testing solutions that ensure the safety, efficacy, and quality of your pharmaceutical products at every stage of development by partnering with us.
-
Hard work is just part of the Ropack ethos, and we prove it daily through our output: high-capacity turnover that does not compromise our quality or excellence. All estimates based on three six-hour shifts per day.